BlossomHill Therapeutics (NASDAQ:BLSM) General Counsel Vincent Paul Liptak Buys 2,500 Shares

BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) General Counsel Vincent Paul Liptak purchased 2,500 shares of the firm’s stock in a transaction dated Friday, August 7th. The stock was bought at an average cost of $15.80 per share, with a total value of $39,500.00. Following the purchase, the general counsel owned 109,212 shares of the company’s stock, valued at approximately $1,725,549.60. This trade represents a 2.34% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Vincent Paul Liptak also recently made the following trade(s):

• On Monday, August 10th, Vincent Paul Liptak acquired 2,200 shares of BlossomHill Therapeutics stock. The shares were bought at an average price of $16.00 per share, with a total value of $35,200.00.

BlossomHill Therapeutics Stock Down 0.1%

BlossomHill Therapeutics stock opened at $15.99 on Tuesday. BlossomHill Therapeutics, Inc. has a one year low of $15.25 and a one year high of $17.25.